First Advantage (NYSE:FA) Given “Outperform” Rating at William Blair

William Blair reiterated their outperform rating on shares of First Advantage (NYSE:FA) in a research note issued to investors on Wednesday morning,RTT News reports.

Several other analysts also recently commented on the company. Citigroup raised their price objective on First Advantage from $19.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 25th. Wolfe Research lowered First Advantage from an “outperform” rating to a “peer perform” rating in a research report on Thursday, October 10th. Finally, Truist Financial reduced their target price on shares of First Advantage from $250.00 to $249.00 and set a “buy” rating for the company in a research note on Monday, July 22nd. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $77.25.

First Advantage Trading Down 3.0 %

Shares of NYSE FA opened at $18.02 on Wednesday. The company’s 50 day simple moving average is $19.14 and its 200 day simple moving average is $17.61. The firm has a market capitalization of $2.62 billion, a P/E ratio of 600.67 and a beta of 1.18. First Advantage has a fifty-two week low of $13.79 and a fifty-two week high of $20.79. The company has a debt-to-equity ratio of 0.61, a current ratio of 4.31 and a quick ratio of 4.31.

First Advantage (NYSE:FA) last issued its earnings results on Tuesday, November 12th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.01. The firm had revenue of $199.10 million for the quarter, compared to analysts’ expectations of $204.39 million. First Advantage had a return on equity of 13.21% and a net margin of 0.65%. The company’s revenue was down .6% compared to the same quarter last year. During the same quarter last year, the business earned $0.25 earnings per share. On average, analysts predict that First Advantage will post 0.82 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of FA. Capital Research Global Investors increased its holdings in shares of First Advantage by 9.4% during the 1st quarter. Capital Research Global Investors now owns 5,777,481 shares of the company’s stock worth $93,711,000 after acquiring an additional 496,898 shares during the last quarter. FMR LLC increased its stake in shares of First Advantage by 50.8% during the third quarter. FMR LLC now owns 5,600,026 shares of the company’s stock worth $111,161,000 after purchasing an additional 1,886,716 shares during the period. Dimensional Fund Advisors LP lifted its holdings in First Advantage by 8.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,131,188 shares of the company’s stock worth $50,314,000 after purchasing an additional 254,219 shares during the last quarter. Boston Partners boosted its stake in First Advantage by 155.3% in the 1st quarter. Boston Partners now owns 1,713,935 shares of the company’s stock valued at $27,841,000 after purchasing an additional 1,042,473 shares during the period. Finally, Emerald Advisers LLC boosted its holdings in First Advantage by 2.1% in the 3rd quarter. Emerald Advisers LLC now owns 1,183,050 shares of the company’s stock valued at $23,484,000 after purchasing an additional 24,217 shares during the period. 94.91% of the stock is owned by institutional investors and hedge funds.

First Advantage Company Profile

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.